JP5922609B2 - 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物 - Google Patents

2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物 Download PDF

Info

Publication number
JP5922609B2
JP5922609B2 JP2013068407A JP2013068407A JP5922609B2 JP 5922609 B2 JP5922609 B2 JP 5922609B2 JP 2013068407 A JP2013068407 A JP 2013068407A JP 2013068407 A JP2013068407 A JP 2013068407A JP 5922609 B2 JP5922609 B2 JP 5922609B2
Authority
JP
Japan
Prior art keywords
aqueous
aqueous composition
amino
bromobenzoyl
sorbitan fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013068407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013227300A5 (cg-RX-API-DMAC7.html
JP2013227300A (ja
Inventor
隆司 森本
隆司 森本
浅田 博之
博之 浅田
恭平 ▲高▼橋
恭平 ▲高▼橋
岡本 智之
智之 岡本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP2013068407A priority Critical patent/JP5922609B2/ja
Publication of JP2013227300A publication Critical patent/JP2013227300A/ja
Publication of JP2013227300A5 publication Critical patent/JP2013227300A5/ja
Application granted granted Critical
Publication of JP5922609B2 publication Critical patent/JP5922609B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2013068407A 2012-03-28 2013-03-28 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物 Expired - Fee Related JP5922609B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013068407A JP5922609B2 (ja) 2012-03-28 2013-03-28 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
JP2012073181 2012-03-28
JP2013068407A JP5922609B2 (ja) 2012-03-28 2013-03-28 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物

Publications (3)

Publication Number Publication Date
JP2013227300A JP2013227300A (ja) 2013-11-07
JP2013227300A5 JP2013227300A5 (cg-RX-API-DMAC7.html) 2016-02-04
JP5922609B2 true JP5922609B2 (ja) 2016-05-24

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013068407A Expired - Fee Related JP5922609B2 (ja) 2012-03-28 2013-03-28 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物

Country Status (9)

Country Link
JP (1) JP5922609B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140139501A (cg-RX-API-DMAC7.html)
CN (1) CN104203224A (cg-RX-API-DMAC7.html)
IN (1) IN2014DN07767A (cg-RX-API-DMAC7.html)
MY (1) MY170840A (cg-RX-API-DMAC7.html)
PH (1) PH12014502171A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201405837YA (cg-RX-API-DMAC7.html)
TW (1) TWI604858B (cg-RX-API-DMAC7.html)
WO (1) WO2013147000A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180016469A (ko) * 2015-06-10 2018-02-14 산텐 세이야꾸 가부시키가이샤 점안제, 및 점안제 방부 효력 유지 방법
JPWO2019117252A1 (ja) * 2017-12-14 2020-12-17 参天製薬株式会社 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸またはその塩を含有する点眼剤
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
JP4674162B2 (ja) * 2003-11-14 2011-04-20 千寿製薬株式会社 アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
CA2716110A1 (en) * 2008-02-21 2009-08-27 Tim Mcnamara Ophthalmic nsaids as adjuvants
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
US9107888B2 (en) * 2011-01-18 2015-08-18 Senju Pharmaceutical Co., Ltd. Aqueous liquid bromfenac composition having preservative efficacy
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
IN2014DN07767A (cg-RX-API-DMAC7.html) 2015-05-15
WO2013147000A1 (ja) 2013-10-03
CN104203224A (zh) 2014-12-10
TWI604858B (zh) 2017-11-11
SG11201405837YA (en) 2014-11-27
KR20140139501A (ko) 2014-12-05
PH12014502171A1 (en) 2014-12-10
TW201343197A (zh) 2013-11-01
JP2013227300A (ja) 2013-11-07
MY170840A (en) 2019-09-10

Similar Documents

Publication Publication Date Title
US11439652B2 (en) Ophthalmic aqueous composition
KR102607126B1 (ko) 안과용 조성물
US20030055051A1 (en) Ophthalmic aqueous pharmaceutical preparation
AU2017348597A1 (en) Ophthalmic Solution Comprising Epinastine
WO2004024164A1 (ja) ラタノプロストを有効成分とする安定な点眼液
JP2013227300A (ja) 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物
TW201902472A (zh) 含有艾瑞布林或其藥劑學上允許的鹽之注射劑
CN103608000B (zh) 含有透明质酸或其盐以及丙二醇的滴眼液
JP5984531B2 (ja) 水性眼科組成物
JP4294276B2 (ja) 点眼剤組成物
JP2015086222A (ja) 安定化された2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物
WO2019123406A1 (en) Novel formulations of vasopressin
JP5460996B2 (ja) 眼科用剤
HK1220393B (en) Aqueous composition containing stabilized 2-amino-3-(4-bromobenzoyl)phenylacetic acid
JP4832015B2 (ja) オキシグルタチオン含有水溶液
WO2016199854A1 (ja) 点眼剤、及び点眼剤防腐効力維持方法
TW201726127A (zh) 含有多佐胺、高分子及硼酸之醫藥組成物
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
JP2021152068A (ja) エピナスチン含有点眼液

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150317

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151215

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20151215

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20160115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160126

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20160222

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160304

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160311

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160414

R150 Certificate of patent or registration of utility model

Ref document number: 5922609

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees